S. Tanaka and S. Arii, Molecular targeted therapy for hepatocellular carcinoma in the current and potential next strategies, Journal of Gastroenterology, vol.361, issue.3, pp.289-296, 2010.
DOI : 10.1007/s00535-011-0387-9

M. A. Patil, I. Gutgemann, J. Zhang, and C. Ho, Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma, Carcinogenesis, vol.26, issue.12, pp.2050-2057, 2005.
DOI : 10.1093/carcin/bgi178

S. Aburatani, F. Sun, S. Saito, and M. Honda, Gene Systems Network Inferred from Expression Profiles in Hepatocellular Carcinogenesis by Graphical Gaussian Model, EURASIP Journal on Bioinformatics and Systems Biology, vol.11, issue.4, p.47214, 2007.
DOI : 10.1093/bioinformatics/bth445

Y. Hoshida, S. Toffanin, A. Lachenmayer, and A. Villanueva, Molecular Classification and Novel Targets in Hepatocellular Carcinoma: Recent Advancements, Seminars in Liver Disease, vol.30, issue.01, pp.35-51, 2010.
DOI : 10.1055/s-0030-1247131

S. Whittaker, R. Marais, and A. X. Zhu, The role of signaling pathways in the development and treatment of hepatocellular carcinoma, Oncogene, vol.110, issue.36, pp.4989-5005
DOI : 10.1038/onc.2010.236

Y. Ito, Y. Sasaki, M. Horimoto, and S. Wada, Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma, Hepatology, vol.70, issue.4, pp.951-958, 1998.
DOI : 10.1002/hep.510270409

L. Zender, A. Villanueva, V. Tovar, and D. Sia, Cancer gene discovery in hepatocellular carcinoma, Journal of Hepatology, vol.52, issue.6, pp.921-929, 2010.
DOI : 10.1016/j.jhep.2009.12.034

C. M. Schmidt, I. H. Mckillop, P. A. Cahill, and J. V. Sitzmann, The role of CAMPMAPK signaling in the regulation of human hepatocellular carcinoma growth in vitro, European Journal of Gastroenterology & Hepatology, vol.11, issue.12, pp.1393-1399, 1999.
DOI : 10.1097/00042737-199912000-00009

K. Iyoda, Y. Sasaki, M. Horimoto, and T. Toyama, Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinoma, Cancer, vol.14, issue.12, pp.3017-3026, 2003.
DOI : 10.1002/cncr.11425

M. Adachi and D. A. Brenner, High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase, Hepatology, vol.40, issue.2, pp.677-685, 2008.
DOI : 10.1002/hep.21991

S. K. Ng, S. Y. Neo, Y. W. Yap, and R. K. Karuturi, Ablation of phosphoinositide-3-kinase class II alpha suppresses hepatoma cell proliferation, Biochemical and Biophysical Research Communications, vol.387, issue.2, pp.310-315, 2009.
DOI : 10.1016/j.bbrc.2009.07.013

D. F. Calvisi, S. Ladu, F. Pinna, and M. Frau, SKP2 and CKS1 Promote Degradation of Cell Cycle Regulators and Are Associated With Hepatocellular Carcinoma Prognosis, Gastroenterology, vol.137, issue.5, pp.1816-1826, 2009.
DOI : 10.1053/j.gastro.2009.08.005

L. Xu, L. Hui, S. Wang, and J. Gong, Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma, Cancer Res, vol.61, pp.3176-3181, 2001.

M. Tomizawa, H. Horie, H. Yamamoto, and T. Matsunaga, Reciprocal expression of CCAAT/enhancer binding proteins alpha and beta in hepatoblastomas and its prognostic significance, Oncol Rep, vol.17, pp.341-344, 2007.

E. Berger, S. Rome, N. Vega, C. Ciancia, and H. Vidal, Transcriptome profiling in response to adiponectin in human cancer-derived cells, Physiological Genomics, vol.42, issue.1, pp.61-70, 2010.
DOI : 10.1152/physiolgenomics.00013.2010

K. J. Chang, J. K. Lin, P. H. Lee, and Y. S. Hsieh, The altered activity of membrane-bound protein kinase C in human liver cancer, Cancer Letters, vol.105, issue.2, pp.211-215, 1996.
DOI : 10.1016/0304-3835(96)04283-8

C. M. Schmidt, I. H. Mckillop, P. A. Cahill, and J. V. Sitzmann, Alterations in guanine nucleotide regulatory protein expression and activity in human hepatocellular carcinoma, Hepatology, vol.26, issue.5, pp.1189-1194, 1997.
DOI : 10.1002/hep.510260516

J. H. Tsai, Y. S. Hsieh, S. J. Kuo, and S. T. Chen, Alteration in the expression of protein kinase C isoforms in human hepatocellular carcinoma, Cancer Letters, vol.161, issue.2, pp.171-175, 2000.
DOI : 10.1016/S0304-3835(00)00597-8

H. Fuke, K. Shiraki, K. Sugimoto, and J. Tanaka, Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cells, Biochemical and Biophysical Research Communications, vol.363, issue.3, pp.738-744, 2007.
DOI : 10.1016/j.bbrc.2007.09.049

M. Kusaba, K. Nakao, T. Goto, and D. Nishimura, Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis, Journal of Hepatology, vol.47, issue.4, pp.546-555, 2007.
DOI : 10.1016/j.jhep.2007.04.017

D. O. Moon, M. O. Kim, Y. H. Choi, and J. W. Hyun, Butein induces G2/M phase arrest and apoptosis in human hepatoma cancer cells through ROS generation, Cancer Letters, vol.288, issue.2, pp.204-213, 2010.
DOI : 10.1016/j.canlet.2009.07.002

J. Sasse, U. Hemmann, C. Schwartz, and U. Schniertshauer, Mutational analysis of acute-phase response factor/Stat3 activation and dimerization., Molecular and Cellular Biology, vol.17, issue.8, pp.4677-4686, 1997.
DOI : 10.1128/MCB.17.8.4677
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC232320

N. Hah and S. T. Lee, An absolute role of the PKC-dependent NF-??B activation for induction of MMP-9 in hepatocellular carcinoma cells, Biochemical and Biophysical Research Communications, vol.305, issue.2, pp.428-433, 2003.
DOI : 10.1016/S0006-291X(03)00788-5

P. J. Chiao, R. Na, J. Niu, and G. M. Sclabas, Role of Rel/NF-?B transcription factors in apoptosis of human hepatocellular carcinoma cells, Cancer, vol.38, issue.8, pp.1696-1705, 2002.
DOI : 10.1002/cncr.10829

A. Alisi, F. Piemonte, A. Pastore, and N. Panera, Glutathionylation of p65NF-kappaB correlates with proliferating/apoptotic hepatoma cells exposed to pro-and anti-oxidants, Int J Mol Med, vol.24, pp.319-326, 2009.

L. F. Wu, G. P. Li, J. D. Su, and Z. J. Pu, Involvement of NF-??B activation in the apoptosis induced by extracellular adenosine in human hepatocellular carcinoma HepG2 cellsThis paper is one of a selection of papers published in this special issue entitled ???Second International Symposium on Recent Advances in Basic, Clinical, and Social Medicine??? and has undergone the Journal's usual peer review process., Biochemistry and Cell Biology, vol.88, issue.4, pp.705-714, 2010.
DOI : 10.1139/O10-008

F. Feo, M. Frau, M. L. Tomasi, S. Brozzetti, and R. M. Pascale, Genetic and Epigenetic Control of Molecular Alterations in Hepatocellular Carcinoma, Experimental Biology and Medicine, vol.234, issue.7, pp.726-736, 2009.
DOI : 10.3181/0901-MR-40

C. Pilarsky, M. Wenzig, T. Specht, H. D. Saeger, and R. Grutzmann, Identification and Validation of Commonly Overexpressed Genes in Solid Tumors by Comparison of Microarray Data, Neoplasia, vol.6, issue.6, pp.744-750, 2004.
DOI : 10.1593/neo.04277

H. C. Sun, M. Li, J. L. Lu, and D. W. Yan, Overexpression of Forkhead box M1 protein associates with aggressive tumor features and poor prognosis of hepatocellular carcinoma, Oncol Rep, vol.25, pp.1533-1539, 2011.

M. F. Yuen, P. C. Wu, V. C. Lai, J. Y. Lau, and C. L. Lai, Expression of c-Myc, c-Fos, and c-Jun in hepatocellular carcinoma, Cancer, vol.18, issue.1, pp.106-112, 2001.
DOI : 10.1002/1097-0142(20010101)91:1<106::AID-CNCR14>3.0.CO;2-2

M. W. Hao, Y. R. Liang, Y. F. Liu, and L. Liu, Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines, World J Gastroenterol, vol.8, pp.203-207, 2002.

K. A. Burns and J. P. Vanden-heuvel, Modulation of PPAR activity via phosphorylation, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1771, issue.8, pp.952-960, 2007.
DOI : 10.1016/j.bbalip.2007.04.018

H. Okano, K. Shiraki, H. Inoue, and T. Yamanaka, Peroxisome proliferator-activated receptor ?? augments tumor necrosis factor family-induced apoptosis in hepatocellular carcinoma, Anti-Cancer Drugs, vol.13, issue.1, pp.59-65, 2002.
DOI : 10.1097/00001813-200201000-00007

M. Toyoda, H. Takagi, N. Horiguchi, and S. Kakizaki, A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells, Gut, vol.50, issue.4, pp.563-567, 2002.
DOI : 10.1136/gut.50.4.563

M. Y. Li, H. Deng, J. M. Zhao, D. Dai, and X. Y. Tan, PPAR?? pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells, World Journal of Gastroenterology, vol.9, issue.6, pp.1220-1226, 2003.
DOI : 10.3748/wjg.v9.i6.1220
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611788

Y. M. Zhou, Y. H. Wen, X. Y. Kang, and H. H. Qian, Troglitazone, a peroxisome proliferator-activated receptor ?? ligand, induces growth inhibition and apoptosis of HepG2 human liver cancer cells, World Journal of Gastroenterology, vol.14, issue.14, pp.2168-2173, 2008.
DOI : 10.3748/wjg.14.2168

H. Koga, M. Harada, M. Ohtsubo, and S. Shishido, Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells, Hepatology, vol.29, issue.5, pp.1086-1096, 2003.
DOI : 10.1053/jhep.2003.50186

K. Tachibana, Application of the Human Hepatoblastoma Cell Lines Inducibly Expressing Peroxisome Proliferator-Activated Receptors (PPARs), ChemInform, vol.127, issue.48, pp.1223-1229, 2007.
DOI : 10.1002/chin.200748279

P. A. Watkins, E. V. Ferrell, . Jr, J. I. Pedersen, and G. Hoefler, Peroxisomal fatty acid ??-oxidation in HepG2 cells, Archives of Biochemistry and Biophysics, vol.289, issue.2, pp.329-336, 1991.
DOI : 10.1016/0003-9861(91)90419-J

T. Gulick, S. Cresci, T. Caira, D. D. Moore, and D. P. Kelly, The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression., Proceedings of the National Academy of Sciences, vol.91, issue.23, pp.11012-11016, 1994.
DOI : 10.1073/pnas.91.23.11012

W. N. Lee, S. Lim, S. Bassilian, E. A. Bergner, and J. Edmond, Fatty Acid Cycling in Human Hepatoma Cells and the Effects of Troglitazone, Journal of Biological Chemistry, vol.273, issue.33, pp.20929-20934, 1998.
DOI : 10.1074/jbc.273.33.20929

M. Maggiora, M. Oraldi, G. Muzio, and R. A. Canuto, Involvement of PPAR?? and PPAR?? in apoptosis and proliferation of human hepatocarcinoma HepG2 cells, Cell Biochemistry and Function, vol.17, issue.7, pp.571-577, 2011.
DOI : 10.1002/cbf.1691

S. Cosulich, N. James, and R. Roberts, Role of MAP kinase signalling pathways in the mode of action of peroxisome proliferators, Carcinogenesis, vol.21, issue.4, pp.579-584, 2000.
DOI : 10.1093/carcin/21.4.579

H. P. Glauert, K. Calfee-mason, Y. Li, and V. Nilakantan, The Role of NF-kappaB in PPARalpha- Mediated Hepatocarcinogenesis, PPAR Res, p.286249, 2008.

R. Shyamsundar, Y. H. Kim, J. P. Higgins, and K. Montgomery, A DNA microarray survey of gene expression in normal human tissues, Genome Biology, vol.6, issue.3, p.22, 2005.
DOI : 10.1186/gb-2005-6-3-r22

A. M. Diehl, D. C. Johns, S. Yang, and H. Lin, Adenovirus-mediated transfer of CCAAT/enhancer-binding protein-alpha identifies a dominant antiproliferative role for this isoform in hepatocytes, J Biol Chem, vol.271, pp.7343-7350, 1996.

T. E. Harris, J. H. Albrecht, M. Nakanishi, and G. J. Darlington, CCAAT/Enhancer-binding Protein-?? Cooperates with p21 to Inhibit Cyclin-dependent Kinase-2 Activity and Induces Growth Arrest Independent of DNA Binding, Journal of Biological Chemistry, vol.276, issue.31, pp.29200-29209, 2001.
DOI : 10.1074/jbc.M011587200

G. D. Lu, C. H. Leung, B. Yan, and C. M. Tan, C/EBP?? Is Up-regulated in a Subset of Hepatocellular Carcinomas and Plays a Role in Cell Growth and Proliferation, Gastroenterology, vol.139, issue.2, pp.632-643, 2010.
DOI : 10.1053/j.gastro.2010.03.051

L. O. Dannenberg and H. J. Edenberg, Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation, BMC Genomics, vol.7, issue.1, p.181, 2006.
DOI : 10.1186/1471-2164-7-181

T. Li, B. Wan, J. Huang, and X. Zhang, Comparison of gene expression in hepatocellular carcinoma, liver development, and liver regeneration, Molecular Genetics and Genomics, vol.45, issue.5, pp.485-492, 2010.
DOI : 10.1007/s00438-010-0530-y